SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Moleculin Biotech, Inc.
@MBRX_InsiderForm 4 Filing: KLEMP WALTER V Surrenders for Taxes $381.12 of $MBRX
TAX WITHHOLDING
⚡ MATERIALITY: 2/10
corporate issuer
Moleculin Biotech, Inc.
Ticker: $MBRX
Transaction Value
$381.12
Price/Share: $0.60
transaction date
2026-06-22
Shares: 635
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KLEMP WALTER V, holds the title of CEO and President at Moleculin Biotech, Inc..
On 2026-06-22, the insider transacted 635 shares.The shares were transacted at a weighted average price of $0.60 per share, resulting in a total market-relevant value of $381.12.
Executive Summary Summary
KLEMP WALTER V (CEO and President) had withheld for taxes $381 of $MBRX
Post-Transaction Position: 31,007 shares
SEC Accession No: 0001437749-26-021611 (CIK: 938419)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.